Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Jing-Ai Fang"'
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
BackgroundStudies have shown that gut dysbiosis contributes to the pathophysiology of type 2 diabetes mellitus (T2DM). Identifying specific gut microbiota dysbiosis may provide insight into the pathogenesis of T2DM.PurposeThis study investigated the
Externí odkaz:
https://doaj.org/article/35b9f5bf5e2a403583ed32904355531b
Autor:
Xue-Ying Cao, Ya-Ni He, Jian-Hui Zhou, Shi-Ren Sun, Li-Ning Miao, Wen Chen, Jing-Ai Fang, Ming Wang, Nian-Song Wang, Hong-Li Lin, Jian Liu, Zhao-Hui Ni, Wen-Hu Liu, Yu Na, Jiu-Yang Zhao, Zhi-Yong Guo, Hong-Guang Zheng, Wei Shi, Geng-Ru Jiang, Guang-Yan Cai, Xiang-Mei Chen
Publikováno v:
Chinese Medical Journal, Vol 131, Iss 23, Pp 2785-2791 (2018)
Background: Automated peritoneal dialysis (APD) can cater to individual needs, provide treatment while asleep, take into account the adequacy of dialysis, and improve the quality of life. Currently, independent research and development of APD machine
Externí odkaz:
https://doaj.org/article/425a48c15baf4c238948fb2ede6ec006
Autor:
Ping Li, Yi-zhi Chen, Hong-li Lin, Zhao-hui Ni, Yong-li Zhan, Rong Wang, Hong-tao Yang, Jing-ai Fang, Nian-song Wang, Wen-ge Li, Xue-feng Sun, Xiang-mei Chen
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-8 (2017)
Abstract Background IgA nephropathy (IgAN) is one of the most common primary glomerular diseases worldwide, but effective therapy remains limited and many patients progress to end-stage renal disease (ESRD). Only angiotensin-converting enzyme inhibit
Externí odkaz:
https://doaj.org/article/d992858fc8b14f9fa696ef3ebb7a3dbc
Autor:
Ying Zheng, Guang-Yan Cai, Li-Qun He, Hong-Li Lin, Xiao-Hong Cheng, Nian-Song Wang, Gui-Hua Jian, Xu-Sheng Liu, Yu-Ning Liu, Zhao-Hui Ni, Jing-Ai Fang, Han-Lu Ding, Wang Guo, Ya-Ni He, Li-Hua Wang, Ya-Ping Wang, Hong-Tao Yang, Zhi-Ming Ye, Ren-Huan Yu, Li-Juan Zhao, Wen-Hua Zhou, Wen-Ge Li, Hui-Juan Mao, Yong-Li Zhan, Zhao Hu, Chen Yao, Ri-Bao Wei, Xiang-Mei Chen
Publikováno v:
Chinese Medical Journal, Vol 130, Iss 20, Pp 2402-2409 (2017)
Background: Chronic kidney disease (CKD) with moderate-to-severe renal dysfunction usually exhibits an irreversible course, and available treatments for delaying the progression to end-stage renal disease are limited. This study aimed to assess the e
Externí odkaz:
https://doaj.org/article/89106fbf012e45b5acf3d74a66f9950a
Autor:
Kang-Kang Song, De-Long Zhao, Yuan-Da Wang, Yong Wang, Xue-Feng Sun, Li-Ning Miao, Zhao-Hui Ni, Hong-Li Lin, Fu-You Liu, Ying Li, Ya-Ni He, Nian-Song Wang, Cai-Li Wang, Ai-Hua Zhang, Meng-Hua Chen, Xiao-Ping Yang, Yue-Yi Deng, Feng-Min Shao, Shu-Xia Fu, Jing-Ai Fang, Guang-Yan Cai, Xiang-Mei Chen
Publikováno v:
Chinese Medical Journal, Vol 130, Iss 8, Pp 885-891 (2017)
Background: Patients on hemodialysis have a high-mortality risk. This study analyzed factors associated with death in patients on maintenance hemodialysis (MHD). While some studies used baseline data of MHD patients, this study used the most recent d
Externí odkaz:
https://doaj.org/article/91a03b04ec984243841b78863b3fc4a1
Autor:
Ming Chen, Jun-zhou Fu, Shuwei Duan, Rong Wang, Wenhu Liu, Xusheng Liu, Meng Liang, Wei Li, Ping Luo, Xiao-Hong Cheng, Xiangmei Chen, Li-qun Song, Ying Li, Jun Zhu, Zhiyong Guo, Ying Lu, Yun Li, Rong-shan Li, Li-Hua Wang, Niansong Wang, Yongli Zhan, Zhang Hao, Zhaohui Ni, Hongli Lin, Shan Lin, Qiang He, Jing-Ai Fang, Guangyan Cai, Qiao-ling Zhou, Ji-feng Sun, Ji-ning Gao, Changying Xing, Lu Ma, Jian Chen, Ai-ping Yin, Yueyi Deng, Li-qun He, Yani He, Jie Wu, Gengru Jiang, Hong-yu Chen, Hong-Tao Yang, Qing Zhu, Shi-ren Sun
Publikováno v:
Journal of Integrative Medicine. 19:111-119
Shenyankangfu Tablet (SYKFT) is a Chinese patent medicine that has been used widely to decrease proteinuria and the progression of chronic kidney disease.This trial compared the efficacy and safety of SYKFT, for the control of proteinuria in primary
Autor:
Zhaohui Ni, Jing-Ai Fang, Chen Yao, Han-Lu Ding, Hong-Tao Yang, Hui-Juan Mao, Gui-Hua Jian, Li-Hua Wang, Wang Guo, Ying Zheng, Zhi-Ming Ye, Xiangmei Chen, Hongli Lin, Yongli Zhan, Niansong Wang, Yu-Ning Liu, Li-qun He, Xusheng Liu, Zhao Hu, Ren-Huan Yu, Li-Juan Zhao, Ya-Ping Wang, Xiao-Hong Cheng, Guangyan Cai, Yani He, Wen-Hua Zhou, Wenge Li
Publikováno v:
Chinese Journal of Integrative Medicine. 25:168-174
To follow up the participants of the randomized clinical trial “Efficacy and Safety of Niaoduqing Particles (尿毒清颗粒) for Delaying Moderate-to-Severe Renal Dysfunction”, and assess the long-term effects of Niaoduqing Particles on delaying
Autor:
Guangyan Cai, Zhaohui Ni, Jie Wu, Xiangmei Chen, Yani He, Jing-Ai Fang, Hong-Tao Yang, Xusheng Liu, Yueyi Deng, Yongli Zhan, Shuwei Duan, Wei Li
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Chronic kidney disease is a common disease. Most chronic kidney diseases evolve from primary glomerulonephritis. Proteinuria is an independent risk factor for the progression of chronic kidney disease. The general consensus is tha
Autor:
Zhaohui Ni, Menghua Chen, Xuefeng Sun, Ying Li, Guangyan Cai, Fuyou Liu, Xiangmei Chen, De-Long Zhao, Yong Wang, Jianhui Zhou, Jing-Ai Fang, Li-Ning Miao, Hongli Lin, Kangkang Song, Shu-Xia Fu, Xiao-Ping Yang, Ai-Hua Zhang, Yueyi Deng, Niansong Wang, Ping Li, Cai-Li Wang, Sai Pan, Ya Ni He, Fengmin Shao
Publikováno v:
Blood purification. 51(2)
Background: Erythropoiesis-stimulating agents (ESAs) constitute an important treatment option for anemia in hemodialysis (HD) patients. We investigated the relationships among the dosage of ESA, erythropoietin resistance index (ERI) scores, and morta
Autor:
Gui-Hua Jian, Wenge Li, Zhi-Ming Ye, Xusheng Liu, Hongli Lin, Niansong Wang, Hui-Juan Mao, Yani He, Jing-Ai Fang, Hong-Tao Yang, Yongli Zhan, Guangyan Cai, Chen Yao, Wen-Hua Zhou, Li-qun He, Zhao Hu, Yu-Ning Liu, Han-Lu Ding, Xiao-Hong Cheng, Xiangmei Chen, Wang Guo, Zhaohui Ni, Ya-Ping Wang, Ri-bao Wei, Li-Hua Wang, Li-Juan Zhao, Ying Zheng, Ren-Huan Yu
Publikováno v:
Chinese Medical Journal
Chinese Medical Journal, Vol 130, Iss 20, Pp 2402-2409 (2017)
Chinese Medical Journal, Vol 130, Iss 20, Pp 2402-2409 (2017)
Background: Chronic kidney disease (CKD) with moderate-to-severe renal dysfunction usually exhibits an irreversible course, and available treatments for delaying the progression to end-stage renal disease are limited. This study aimed to assess the e